Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
(NASDAQ: PSNL) Delayed: 16.02 +0.14 (0.88%)
Previous Close $15.88    52 Week High $ 
Open $15.86    52 Week Low $ 
Day High $16.13    P/E N/A 
Day Low $15.80    EPS $ 
Volume 370,237